Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Cellular Physiology|October 23, 2014
Enhanced phenotypic alterations of alveolar type II cells in response to Aflatoxin G1 -induced lung inflammationHaitao Shen, Chunping Liu, Peilu Shao, et al.
Frontiers in Immunology|April 10, 2023
Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysisHao Qin, Futao Liu, Yaozhong Zhang, et al.
Optics Express|October 14, 2022
Apparent change of the 3C/3D line intensity ratio in neonlike ionsZhihao Yang, Zhencen He, Gang Xiong, et al.
Cancers|February 25, 2023
CD39-Expressing CD8<sup>+</sup> T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell CarcinomaMeitong Liu, Yaning Zhao, Zhuoyun Xiao, et al.
Cell Reports. Medicine|March 6, 2026
Spatial omics study reveals molecular-cellular dynamics of tumor ecosystem in esophageal squamous-cell carcinoma initiation and progressionZhao Liu, Wenhao Zhou, Lei Li, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 1, 2022
Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in ChinaYang Yang, Lijie Tan, Jian Hu, et al.
Annals of Surgical Oncology|July 1, 2026
Lymph Node Yield and Disease-Free Survival After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma: A Multicenter, Retrospective Cohort StudyHuilai Lv, Zuopeng Wang, Xuefeng Leng, et al.
BMC Medicine|March 7, 2023
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCCYong Li, Aiping Zhou, Shuoyan Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 10, 2025
Lymph node dissection in neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter real-world studyChunji Chen, Huilai Lv, Jinbo Zhao, et al.
JAMA Surgery|March 19, 2025
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell CarcinomaXufeng Guo, Chunji Chen, Jinbo Zhao, et al.
Pageof 9